8th May 2009 14:43
Hutchison China MediTech Limited ("Chi-Med")
(AIM: HCM)
Results of Annual General Meeting
London: Friday, 8 May 2009: Chi-Med today announces that all ordinary resolutions and special resolution put to its Annual General Meeting ("AGM") held on 8 May 2009 were duly passed. The poll results of the resolutions were as follows:
|
Number of Votes (%)* |
||||
|
Ordinary Resolutions |
For |
Against |
Withheld |
|
|
1 |
To consider and adopt the statement of audited accounts and the reports of the directors and independent auditor for the year ended 31 December 2008. |
39,331,521 (100.000000%) |
0 (0.000000%) |
0 (0.000000%) |
|
2(a) |
To re-elect Mr Shigeru Endo as a director. |
39,331,488 (99.999916%) |
33 (0.000084%) |
0 (0.000000%) |
|
2(b) |
To re-elect Ms Edith Shih as a director. |
39,331,488 (99.999916%) |
33 (0.000084%) |
0 (0.000000%) |
|
2(c) |
To re-elect Prof Christopher Huang as a director. |
39,331,518 (99.999992%) |
3 (0.000008%) |
0 (0.000000%) |
|
2(d) |
To re-elect Mr Christopher Nash as a director. |
39,331,518 (99.999992%) |
3 (0.000008%) |
0 (0.000000%) |
|
3 |
To re-appoint PricewaterhouseCoopers as the auditor of the Company and authorise the board of directors to fix the auditor's remuneration. |
39,331,521 (100.000000%) |
0 (0.000000%) |
0 (0.000000%) |
|
4(a) |
Item 4(A) of the notice of the Meeting (To grant a general mandate to the directors of the Company to issue additional shares) |
39,331,491 (99.999924%) |
30 (0.000076%) |
0 (0.000000%) |
|
Special Resolution |
||||
|
4(b) |
Item 4(B) of the notice of the Meeting (To disapply pre-emption rights) |
39,331,391 (99.999669%) |
130 (0.000331%) |
0 (0.000000%) |
|
Ordinary Resolution |
||||
|
4(c) |
Item 4(C) of the notice of the Meeting (To grant a general mandate to the directors of the Company to repurchase shares of the Company) |
39,331,521 (100.000000%) |
0 (0.000000%) |
0 (0.000000%) |
* All percentages rounded to 6 decimal places
As at the date of the AGM, the number of issued shares of Chi-Med was 51,229,174, which was the total number of shares entitling the holders to attend and vote on the ordinary resolutions and special resolution proposed at the AGM.
Ends
Enquiries
|
Citigate Dewe Rogerson
Anthony Carlisle
David Dible
|
Telephone: +44 (0) 20 7638 9571
+44 (0) 7973 611 888
+44 (0) 7967 566 919
|
About Chi-Med
Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing, and selling pharmaceuticals, health supplements and other consumer health and personal care products derived from Traditional Chinese Medicine and botanical ingredients.
Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.
Related Shares:
Hutchmed